CLINICAL_TRIALS
research
· 2018-11-07
Clinical Trial Update: A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients [Phase 4]
Summary
Phase 4 pharmacokinetic study evaluating tacrolimus ER dosing in obese kidney transplant recipients; results completed in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Illinois at Chicago | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2018-11-07